AstraZeneca PLC (AZN) is a publicly traded Healthcare sector company. As of May 20, 2026, AZN trades at $187.48 with a market cap of $285.23B and a P/E ratio of 0.00. AZN moved +1.54% today. Year to date, AZN is +105.50%; over the trailing twelve months it is +168.11%. Its 52-week range spans $61.24 to $212.71. Analyst consensus is strong buy with an average price target of $214.28. Rallies surfaces AZN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes AZN SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $187.48 |
| Market Cap | $285.23B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 1.59% |
| 52-Week High | $212.71 |
| 52-Week Low | $61.24 |
| Volume | 1.42M |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
15 analysts cover AZN: 0 strong buy, 13 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $214.28.